Pulmonx Co. (NASDAQ:LUNG) Receives $12.07 Consensus Price Target from Analysts
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been given an average rating of “Moderate Buy” by the nine brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month […]
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been given an average rating of “Moderate Buy” by the nine brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month […]
